Receptors, Interleukin-8B
"Receptors, Interleukin-8B" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
High-affinity G-protein-coupled receptors for INTERLEUKIN-8 present on NEUTROPHILS; MONOCYTES; and T-LYMPHOCYTES. These receptors also bind several other CXC CHEMOKINES.
MeSH Number(s)
D12.776.543.750.100.160.500.750.750
D12.776.543.750.705.852.125.500.750.750
D12.776.543.750.705.852.420.421.750
D23.050.301.264.035.605.500.750.750
D23.101.100.110.605.500.750.750
Concept/Terms
Receptors, Interleukin-8B- Receptors, Interleukin-8B
- Receptors, Interleukin 8B
- CDw128b Antigens
- CXC Chemokine Receptor 2
- CXCR2 Protein
- Receptors, CXCR2
- Interleukin-8 Receptor Type B
- Interleukin 8 Receptor Type B
- Interleukin-8 Receptors B
- Interleukin 8 Receptors B
- Interleukin-8 Receptors Type B
- Interleukin 8 Receptors Type B
- Interleukin-8B Receptor
- Interleukin 8B Receptor
- Receptor, Interleukin-8B
- Interleukin-8B Receptors
- Interleukin 8B Receptors
- Antigens, CDw128b
- CXCR2 Receptors
Below are MeSH descriptors whose meaning is more general than "Receptors, Interleukin-8B".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.100]
- Receptors, Chemokine [D12.776.543.750.100.160]
- Receptors, CXCR [D12.776.543.750.100.160.500]
- Receptors, Interleukin-8 [D12.776.543.750.100.160.500.750]
- Receptors, Interleukin-8B [D12.776.543.750.100.160.500.750.750]
- Receptors, Immunologic [D12.776.543.750.705]
- Receptors, Cytokine [D12.776.543.750.705.852]
- Receptors, Chemokine [D12.776.543.750.705.852.125]
- Receptors, CXCR [D12.776.543.750.705.852.125.500]
- Receptors, Interleukin-8 [D12.776.543.750.705.852.125.500.750]
- Receptors, Interleukin-8B [D12.776.543.750.705.852.125.500.750.750]
- Receptors, Interleukin [D12.776.543.750.705.852.420]
- Receptors, Interleukin-8 [D12.776.543.750.705.852.420.421]
- Receptors, Interleukin-8B [D12.776.543.750.705.852.420.421.750]
- Biological Factors [D23]
- Antigens [D23.050]
- Antigens, Surface [D23.050.301]
- Antigens, Differentiation [D23.050.301.264]
- Antigens, CD [D23.050.301.264.035]
- Receptors, Chemokine [D23.050.301.264.035.605]
- Receptors, CXCR [D23.050.301.264.035.605.500]
- Receptors, Interleukin-8 [D23.050.301.264.035.605.500.750]
- Receptors, Interleukin-8B [D23.050.301.264.035.605.500.750.750]
- Biological Markers [D23.101]
- Antigens, Differentiation [D23.101.100]
- Antigens, CD [D23.101.100.110]
- Receptors, Chemokine [D23.101.100.110.605]
- Receptors, CXCR [D23.101.100.110.605.500]
- Receptors, Interleukin-8 [D23.101.100.110.605.500.750]
- Receptors, Interleukin-8B [D23.101.100.110.605.500.750.750]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Interleukin-8B".
This graph shows the total number of publications written about "Receptors, Interleukin-8B" by people in Harvard Catalyst Profiles by year, and whether "Receptors, Interleukin-8B" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 1 | 2 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 6 | 6 |
| 2001 | 1 | 1 | 2 |
| 2002 | 1 | 1 | 2 |
| 2003 | 1 | 1 | 2 |
| 2005 | 3 | 0 | 3 |
| 2007 | 1 | 1 | 2 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 2 | 1 | 3 |
| 2012 | 0 | 2 | 2 |
| 2013 | 1 | 1 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 3 | 4 |
| 2017 | 1 | 1 | 2 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 3 | 4 |
| 2020 | 1 | 1 | 2 |
| 2021 | 0 | 2 | 2 |
Below are the most recent publications written about "Receptors, Interleukin-8B" by people in Profiles.
-
The IL-8-CXCR1/2 axis contributes to diabetic kidney disease. Metabolism. 2021 08; 121:154804.
-
Age-related changes in the local milieu of inflamed tissues cause aberrant neutrophil trafficking and subsequent remote organ damage. Immunity. 2021 07 13; 54(7):1494-1510.e7.
-
Interleukin-8 Receptors CXCR1 and CXCR2 Are Not Expressed by Endothelial Colony-forming Cells. Stem Cell Rev Rep. 2021 04; 17(2):628-638.
-
Astrocyte- and Neuron-Derived CXCL1 Drives Neutrophil Transmigration and Blood-Brain Barrier Permeability in Viral Encephalitis. Cell Rep. 2020 09 15; 32(11):108150.
-
Epigenetic therapy inhibits metastases by disrupting premetastatic niches. Nature. 2020 03; 579(7798):284-290.
-
Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5. PLoS One. 2020; 15(1):e0228015.
-
Disrupted CXCR2 Signaling in Oligodendroglia Lineage Cells Enhances Myelin Repair in a Viral Model of Multiple Sclerosis. J Virol. 2019 09 15; 93(18).
-
Atypical complement receptor C5aR2 transports C5a to initiate neutrophil adhesion and inflammation. Sci Immunol. 2019 05 10; 4(35).
-
Novel Paracrine Functions of Smooth Muscle Cells in Supporting Endothelial Regeneration Following Arterial Injury. Circ Res. 2019 04 12; 124(8):1253-1265.
-
Blastemal progenitors modulate immune signaling during early limb regeneration. Development. 2019 01 02; 146(1).